Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4) by Arévalo Pinzón, Gabriela et al.
Arévalo-Pinzón et al. Malaria Journal 2013, 12:356
http://www.malariajournal.com/content/12/1/356RESEARCH Open AccessAnnotation and characterization of the Plasmodium
vivax rhoptry neck protein 4 (PvRON4)
Gabriela Arévalo-Pinzón1,2, Hernando Curtidor1,2, Jesica Abril1 and Manuel A Patarroyo1,2*Abstract
Background: The tight junction (TJ) is one of the most important structures established during merozoite invasion
of host cells and a large amount of proteins stored in Toxoplasma and Plasmodium parasites’ apical organelles are
involved in forming the TJ. Plasmodium falciparum and Toxoplasma gondii apical membrane antigen 1 (AMA-1) and
rhoptry neck proteins (RONs) are the two main TJ components. It has been shown that RON4 plays an essential
role during merozoite and sporozoite invasion to target cells. This study has focused on characterizing a novel
Plasmodium vivax rhoptry protein, RON4, which is homologous to PfRON4 and PkRON4.
Methods: The ron4 gene was re-annotated in the P. vivax genome using various bioinformatics tools and taking
PfRON4 and PkRON4 amino acid sequences as templates. Gene synteny, as well as identity and similarity values
between open reading frames (ORFs) belonging to the three species were assessed. The gene transcription of
pvron4, and the expression and localization of the encoded protein were also determined in the VCG-1 strain by
molecular and immunological studies. Nucleotide and amino acid sequences obtained for pvron4 in VCG-1 were
compared to those from strains coming from different geographical areas.
Results: PvRON4 is a 733 amino acid long protein, which is encoded by three exons, having similar transcription
and translation patterns to those reported for its homologue, PfRON4. Sequencing PvRON4 from the VCG-1 strain
and comparing it to P. vivax strains from different geographical locations has shown two conserved regions
separated by a low complexity variable region, possibly acting as a “smokescreen”. PvRON4 contains a predicted
signal sequence, a coiled-coil α-helical motif, two tandem repeats and six conserved cysteines towards the carboxy-
terminus and is a soluble protein lacking predicted transmembranal domains or a GPI anchor. Indirect
immunofluorescence assays have shown that PvRON4 is expressed at the apical end of schizonts and co-localizes at
the rhoptry neck with PvRON2.
Conclusions: Genomic, transcriptional and expression data reported for PvRON4, as well as its primary structure
characteristics suggest that this protein participates in reticulocyte invasion, as has been shown for its homologue
PfRON4.
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Malaria is a parasitic disease, primarily affecting preg-
nant females and children aged less than five years in
tropical and subtropical areas around the world, mainly
in sub-Saharan Africa [1]. A substantial increase in cases
of Plasmodium vivax malaria has been reported recently
in Asia and Latin America [2]. Such data, added to an
increase in the number of severe disease reports, death* Correspondence: mapatarr.fidic@gmail.com
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distribution, and reproduction in any mediumand resistance to first-generation anti-malarial drugs
attributed to P. vivax [3-5], emphasize the need for
developing effective control tools and acknowledging
this parasite species as an important agent of vector-
transmitted tropical diseases.
Basic research around the world into P. vivax has lagged
behind compared to Plasmodium falciparum mainly due
to a lack of in vitro continuous culturing as this requires a
large amount of reticulocytes for maintaining and pro-
pagating this parasite species [6]. Among the various stra-
tegies being used to overcome this problem, comparativeCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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adapting P. vivax strains to Aotus monkeys [7], have
allowed the identification during the last few years of
several antigens in P. vivax which could be participating
in invasion [8-11].
The merozoite’s rapid and coordinated invasion of red
blood cells (RBC) is mediated by initial contact with the
host cell, re-orientation of the parasite’s apical pole and
active internalization into the host cell involving many
sub-compartmentalized proteins localized in secretory
organelles, such as micronemes and rhoptries [12]. The
rhoptries are pear-shaped structures having two com-
partments called neck and bulb; despite being present in
all parasites belonging to the phylum Apicomplexa, their
size and number varies according to the target cell being
invaded [13]. Transmission electron microscopy studies
of P. falciparum and Toxoplasma gondii have revealed
that some antigens are site-specifically distributed in a
rhoptry [14,15]; such distribution seems to be the rule
concerning important organization facilitating protein
function in tight junction (TJ) and/or parasitophorous
vacuole (PV) formation. Proteomics analysis of T. gondii
rhoptries has shown minimum overlapping with P. fal-
ciparum proteins, except for some proteins localized in
the rhoptry neck (RON), which could be involved in
functions common to both parasites [16]. RON2 [17],
RON4 [18] and RON5 [19] proteins have been identified
to date in P. falciparum, forming part of a high molecular
weight complex interacting with a microneme-derived
protein called apical membrane antigen 1 (AMA-1) [20].
The assembly of this macromolecular complex allows TJ
formation or irreversible binding which is important since
this acts as a foothold for the parasite’s motor machinery
to propel the parasite into the PV for successful invasion.
Surface plasmon resonance (SPR) studies have deter-
mined that the PfRON2 binding region to PfAMA-1 lies
within residues 2,020-2,059 and contains two conserved
cysteines which are strongly implicated in the peptide’s
structure [21]. Crystallization of the PfAMA-1/PfRON2
complex has shown that the peptide binds in a U-shape
to the AMA-1 ectodomain, inducing a conformational
change in AMA-1 domain II (DII) [21], similar to that
found for the interaction between TgAMA-1/TgRON2
[21]. Interestingly, different methodological approaches
have proposed that blocking the interaction between
AMA-1 and RON2 inhibits parasite invasion of its host
cell [20,22,23]. Knowledge regarding these interactions
has been key in understanding 4G2 antibody’s invasion-
inhibitory action (binding to AMA-1 DII), thereby
impeding displacement in domain II and thus blocking
interaction with RON2 [21].
PfRON4 is the second most studied antigen from the
aforementioned complex after AMA-1 and RON2. This
is one of the most important proteins as it is most likelyessential in merozoite and sporozoite invasion of their
respective host cells [24]. No evidence has been ad-
vanced to date regarding the role played by RON4 in TJ
formation and it is not known which proteins interact
directly with it within the complex. However, RON4 has
been the only protein from the whole complex that has
been convincingly localized to junction constriction
during invasion [25]. In fact, immunoprecipitation as-
says with Plasmodium yoelii merozoite proteins have
supported RON4 (PyP140)-AMA1 interaction but
PyRON2 and PyRON5 have not been identified within
the complex. Importantly, immunogenicity studies have
shown that PfRON4 sequences elicit immunogenic re-
sponses in natural human malaria infection, sugges-
ting their exposure to the immune system during
host cell invasion as has been proposed for other im-
portant antigens, such as merozoite surface proteins
(MSP) [26].
The importance of RON proteins in P. falciparum and
in the model Apicomplexa parasite, T. gondii, has led to
interest in identifying the functional characterization of
RON proteins in other genera, such as Neospora, Cryp-
tosporidium, Babesia, and other Plasmodium species
[8,27]. Recent studies have shown that although most
proteins from the complex are conserved within Api-
complexa, some are exclusive to certain members [27].
Such divergence regarding the complex’s molecular
composition suggests differences in TJ formation among
Apicomplexa members and partly explains host cell spe-
cificity among parasites [27].
This study was thus aimed at making a correct annota-
tion for pvron4 in the P. vivax genome and characterizing
PvRON4 in late-stage schizonts from the VCG-1 strain.
PvRON4 is a 733 amino acid long protein containing
typical characteristics concerning antigens involved in
invasion, such as having a signal peptide, coiled-coil
α-helical motifs, low complexity regions, and long
conserved segments. Immunofluorescence studies using
rhoptry and membrane markers as reference have shown
that PvRON4, just like its homologue in P. falciparum
(PfRON4), is localized in the rhoptries and could thus be
participating in invasion.
Methods
Bioinformatics tools
The Basic Local Alignment Search Tool (BLAST), from
the National Center for Biotechnology Information
(NCBI), was used to find the homologous gene to pfron4
(PF11_0168) and pkron4 (PKH_091340) in the P. vivax
genome. The presence of and boundaries between
pvron4 introns and exons was evaluated using Genscan
[28], Spidey [29] and tBlastn. Gene structure, open read-
ing frame (ORF) transcription direction, nucleotide and
amino acid level identity, and similarity values between
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vivax were taken into account for synteny analysis.
Bioinformatics tools, such as SignalP [30], were used
for evaluating the presence of a signal peptide in
PvRON4 sequence; TMHMM, Polyphobius and PredGPI
were used to predict transmembranal domains and
glycosylphosphatidylinositol (GPI) anchors, since the
presence of these motifs and domains is typical of
several antigens considered as candidates for an anti-
malarial vaccine [31-33]. Sequence tandem repeats extrac-
tion and architecture modelling (XSTREAM, variable ‘X’)
was used for finding repeat sequences and the simple
modular architecture research tool (SMART) [34] with
Globplot for searching for other important motifs and
domains.
DNA, RNA and protein source and cDNA synthesis
A blood sample taken from an Aotus sp. monkey
infected with the Colombian P. vivax Guaviare 1 strain
(VCG-1) was used for extracting nucleic acids and pro-
teins. The VCG-1 strain had been cultured via successive
passes in vivo in Aotus sp. monkeys from the primate
station in Leticia, Amazonas, as thoroughly described [7].
The monkeys were kept under constant care, supervised
by a primatologist, according to the conditions established
by Colombian Animal Protection law (law 84/1989) and
Corpoamazonía (the Colombian entity regulating environ-
mental matters in the region) (resolution 00066, September
13, 2006).
A schizont-enriched sample was obtained using a
discontinuous Percoll gradient (GE Healthcare) and
genomic DNA (gDNA) was isolated using a Wizard
genomic DNA purification kit (Promega), following the
manufacturer’s recommendations. RNA was isolated
from the parasite using the Trizol method [35], followed
by treatment with RQ1 RNase-free DNase (Promega).
Purified RNA and gDNA integrity was examined by
electrophoresis on agarose gels. Five microlitres of RNA
were taken as template for cDNA synthesis, using a one-
step RT-PCR SuperScript III kit (Invitrogen).
Primer design and pvron4 amplification
Based on bioinformatics analysis, the PVX_091435 gene
ID gene was re-annotated (Figure 1) and such informa-
tion was used to design primers for amplifying pvron4
from gDNA and cDNA. pvron4G1 5’- ATG TCT CGT
AAA AGG GTT TT-3’ and pvron4G2 5’-CAA GTC
TTC AAA AAT GAG ATT T-3’ primers amplified from
predicted ATG until the stop codon. These primers were
included in PCR reactions with Gotaq flexi DNA poly-
merase (Promega) with gDNA or RT-PCR products from
samples treated with or without reverse transcriptase (RT+
and RT- respectively) at 25 μL final volume, according to
the manufacturer’s instructions. Amplification conditionswere as follows: a 5-min cycle at 95°C, followed by 35
cycles of 1 min at 56°C, 3 min at 72°C and 1 min at 95°C.
A final extension step lasted 10 min at 72°C. A pvron1
region (~1053 from cDNA) transcribed during the
erythrocyte phase was amplified using direct 5′- atg GCG
AAG GAG CCC AAG TG-3′ and reverse 5′- ATC CCT
AGC AAT GCT TCG -3′ primers for evaluating cDNA
contamination by gDNA [36].
Primers called ExtD: 5’-TCC AGA CGT GTC AGA
GTG-3’ and ExtR: 5’- TAG CTT CGT TCC TTT GGG-
3’ were also designed; they were localized 72 bp up-
stream of the start codon and 49 bp downstream the
stop codon of the pvron4 gene, respectively. Amplifica-
tion conditions from gDNA and cDNA were the same as
those used for the pvron4G1 and pvron4G2 primers. The
polymerase chain reaction (PCR) products were visua-
lized on 1% agarose gel and then purified with a Wiz-
ard PCR preps kit (Promega). PCR products from
gDNA and cDNA were cloned in pGEM-T (Promega)
and pEXP5-CT/TOPO vectors (Invitrogen) respect-
ively by TA cloning. Positive clones and PCR prod-
ucts were sequenced in an ABI PRISM 310 Genetic
Analyzer. The sequences were analyzed using CLC
DNA Workbench (CLC bio) and compared to the
Sal-1, Mauritania I and India VII strain sequences [37]
using Clustal W [38].
Obtaining polyclonal antibodies against PvRON4, Pv12
and PvRON2
Taking the amino acid sequence predicted for PvRON4
as reference, two 20 residue-long, B-epitope peptides
were selected, chemically synthesized in solid phase and
cysteine and glycine (CG) were added to amino and
carboxy termini for polymerization. Synthetized peptides
were numbered 36114 (CG181GSASESAAPSEEKASEE
NVP200GC) and 36115 (CG719AAEVEKRGFDEDYIQEEI
KN 738GC). These peptides were selected based on high
average values for Parker’s antigenicity, hydrophilicity
and solvent accessibility using Antheprot software [39]
and high values obtained when using Bepipred (0.35
default threshold and 75% specificity) [40]. It was also
taken into account that the peptides corresponded to
different protein regions, for detecting fragments in case
of proteolytic processing occurring in PvRON4.
Seven to eight week-old BAlb/C mice were intraperi-
toneally (ip) inoculated with 75 μg of each polymeric
peptide emulsified in Freund’s complete adjuvant (FCA)
on day 0 for evaluating PvRON4 expression in VCG-1
strain schizonts. Three boosters were given on days 30,
45 and 60 using the same peptides emulsified in Freund’s
incomplete adjuvant (FIA). Polyclonal antibodies against
Pv12 localized on the membrane and PvRON2 localized
in the rhoptries were obtained for PvRON4 localization
studies. Peptide 35520 (CG1674KLQQEQNELNEEKERQ
Figure 1 Re-annotation of pvron4 within the PviS_CM000450 contig (above) schematic representation of PVX_091435 from the
pvron4 gene in PlasmoDB and annotation suggested after bioinformatics and experimental analysis. The start positions for the ORFs
within the contig are shown and the transcription direction. PVX_091435 was originally annotated as an 8,437 bp gene consisting of six
exons. The re-annotation proposed has two ORFs where pvron4 start codon (shown in bold) is located 5,780 bp downstream the start
codon initially reported in PlasmoDB. Amplification of the expected PCR products for pvron4 from gDNA and cDNA are shown on the
agarose gel. Lane 1: amplification of ron4 from gDNA. Lane 2: amplification of ron4 from a sample of RNA from VCG-1 strain schizonts
treated with reverse transcriptase (RT+). Lane 3: amplification of ron4 from a sample of RNA from VCG-1 schizonts without reverse
transcriptase (RT-). MWM: molecular weight marker. Lane 4. Amplification of a pvron1 fragment from an RT+ sample. Lane 5: pvron1
amplification from an RT- sample.
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CG-AKIRVRKRSGEEYDKEIFNL-GC and CG-AHFEFA
TTPDDQNSVSEPRA-GC were used for Pv12 [10].
These peptides were inoculated into negative New
Zealand rabbits for recognizing P. vivax-derived pro-
teins by Western blot, as described previously [8,10].
Animal sera was collected and stored at -70°C for
later studies. Animal immunization and bleeding was
done according to Colombian animal protection rec-
ommendations (Law 84/1989) and Resolution 8430/
1993 for handling live animals for research or experi-
mentation purposes.PvRON4 immunodetection assays
ELISA
A previously described ELISA test was used for determi-
ning inoculated peptide immunogenicity [19]. Briefly, each
of the inoculated peptides was sown in 96-well ELISA
plates and incubated at 1:100 dilution of each serum. A
peroxidase-coupled, anti-mouse antibody was used as
secondary antibody (Vector Laboratories), diluted 1:5,000.
Western blot
The proteins were extracted from a P. vivax schizont-
enriched sample and separated on an SDS-PAGE gel, as
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cellulose membrane were incubated with pre-immune or
immune serum. In a parallel assay, immune serum was
pre-incubated with inoculated polymeric peptides before
being incubated with the nitrocellulose membrane. A
peroxidase-coupled, anti-mouse IgG antibody was used
as secondary antibody (Vector Laboratories).
Indirect immunofluorescence
A suspension of erythrocytes parasitized by P. vivax
VCG-1 was washed thrice with PBS (pH 7.2–7.4), then
centrifuged at 2,500×g for 4 min and suspended in a 1:1
PBS–fetal bovine serum solution. This solution was
seeded on eight-well multitest slides and left to dry at
room temperature for 24 hr. Parasites slides were fixed
using a 4% formaldehyde solution followed by three
washes with PBS. The slides were blocked with 1%
skimmed milk in PBS for 30 min and incubated with
anti-PvRON4 primary antibody obtained in mice and
anti-Pv12 or anti-PvRON2 antibodies in 1:40 dilution.
Fluorescein-labelled anti-rabbit IgG (FITC) (Vector
Laboratories) and rhodamine-labelled anti-mouse IgG
(Millipore) were used as secondary antibody for 60 min,
followed by three PBS washes. Parasite nuclei were
stained with a 2 μg/mL solution of 4’,6-diamidino-2-
phenylindole (DAPI) for 20 min at room temperature
and fluorescence was visualized in a fluorescence micro-
scope (Olympus BX51) using an Olympus DP2 camera
and Volocity software (Perkin Elmer).
Statistical analysis
Differences in antibody production between pre-immune
and post-third immunization sera obtained from ELISA
were evaluated using non-parametric Wilcoxon signed
rank test.
Results and discussion
In-silico re-annotation of the ron4 gene in Plasmodium
vivax
The search for the pvron4 gene was initially made using
the PfRON4 protein amino acid sequence (PF11_0168)
containing 1,201 residues [18]. tBlastn results revealed a
nucleotide region having a high probability of containing
pvron4 in the PviS_CM000450 contig localized in
chromosome 9. Analysis showed a pvron4 segment run-
ning from nucleotide 516,555 to 514,248 corresponding
to residues 484 to 1,201 in P. falciparum; however, the
beginning of pvron4 could not be found. The P. knowlesi
RON4 (PKH_091340) amino acid sequence reported in
PlasmoDB was used to overcome this. Plasmodium
knowlesi is a parasite which infects Macaca fascicularis
monkeys and shares a close phylogenetic relationship
with P. vivax as shown in small subunit rRNA analysis
and the high identity and similarity values betweenorthologous proteins [9,41]. This led to finding that
pvron4 was located between nucleotide 516,904 and
514,248, having a ~2,657 bp length. Interestingly, a puta-
tive gene called PVX_091435 (8,437 bp and six exons)
was found to be annotated in this nucleotide region
which is also found when PfRON4 and PkRON4 amino
acid sequences are used as templates for Blastp analysis
(Figure 1). However, analyzing the presence of and
boundaries for the exons/introns proposed for the
PVX_091435 gene indicated that its gene structure had
not been correctly annotated (Figure 1). In-silico analysis
of this genome locus suggested that there were two
ORFs; the first had high similarity (60%) with a P. falcip-
arum serine esterase and began at position 522,681 of
the PviS_CM000450 contig and ended at nucleotide
518,314 (Figure 1) while the second ORF was found
downstream serine esterase in position 516,904 and
referred to pvron4. The suggested pvron4 structural
region had three exons; a first short one ~78 bp (in ORF -1)
having consensus intron splice sites, a second long ~2,019
bp (in ORF -2) having its respective donor site sequence
ending with a ~189 bp exon (in ORF -3) (Figure 1).
Once ron4 structure had been annotated, a syntenic
analysis was made for evaluating neighboring genes’
structure (number of introns and exons), transcription
orientation and determining identity (ID) and similarity
(SI) values at protein level. PvRON4 amino acid align-
ment with PfRON4 and PkRON4 showed that ID and SI
values were greater with PkRON4 (Figure 2) thereby
agreeing with the close relationship between these two
parasite species. This coincided with previous studies
showing greater similarity between P. vivax and P.
knowlesi proteins than with other Plasmodium species
[10,11]. Conservation was also found regarding the
structure of genes upstream and downstream ron4 in P.
falciparum, P. vivax and P. knowlesi, having 61.1%-97%
and 77.6%-99.7% amino acid ID and SI values for Pk-Pv
respectively, and 33.6%-88% and 54%-100% for Pf-Pv,
respectively (Figure 2).
Transcription and analysis of the VCG-1 strain pvron4
sequence
The pvron4 gene was amplified from gDNA and cDNA
to confirm its presence and re-annotation. Figure 1
shows that a ~2,600 bp gDNA product was obtained
and a ~2,200 bp product from cDNA (RT+) thereby
confirming the presence of intron regions. No amplifica-
tion was observed from RT- samples, indicating that the
cDNA preparation had no gDNA contamination. PCR
amplification of the pvron4 encoding sequence suggested
the presence of this transcript (~2,200 bp) in mature P.
vivax blood stages, similar to that found for pvron1
(Figure 1) [36]. The pvron4 transcription time coincided
with that displayed by pfron4 (42-48 hr of the intra-
Figure 2 Syntenic analysis of the chromosome region containing ron4 in Plasmodium knowlesi, Plasmodium falciparum and
Plasmodium vivax. Blue shows ron4 location, grey shows open reading frames (ORFs) upstream and downstream ron4. Each ORF’s accession
number in PlasmoDB is indicated, as well as amino acid similarity and identity levels between Pf-Pv and Pv-Pk.
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analysis of P. falciparum has shown that most ORFs
transcribed at the end of the intra-erythrocyte cycle are
expressed during and participate in host cell invasion
[42,43].
When aligning pvron4 gDNA and cDNA nucleotide
sequences obtained from sequencing three independent
clones it was found that the gDNA was 2,573 bp while
cDNA was 2,202 bp. The gene consisted of three exons
and two intron regions, encoding a 733 residue-long
protein (~80 kDa); this genomic organization coincided
with that proposed by bioinformatics analysis (Figure 1).
When comparing the sequences obtained from VCG-1
to those reported for Sal-1 (PVX_091435), a match was
found from nucleotide 516,904 onwards within the
contig, coinciding with previous analysis proposed for
pvron4 localization and structure (Figure 1). The align-
ment showed that exon 2 was shorter in VCG-1 (1,932
bp) compared to Sal-1 (2,019 bp) due to deletions cor-
responding to a loss of 81 nt (27 amino acid residues)
between amino acids 235-262 and a deletion of two trip-
lets (GTG AGG) encoding glycine (G671) and glutamic
acid (E672). According to bioinformatics analysis, exon
two encoded a low complexity region rich in tandem
repeats (TR) (Figure 3). Analysis also revealed a change
at nucleotide level involving T for G in position 810
(T810G); this substitution led to a valine (V) being
changed for a glycine (G) in position 199 (V199G). A
substitution of A for G was found in VCG-1 strain
intron 2 compared to Sal-1. VCG-1 gDNA and cDNA
consensus sequences were deposited in [GenBank:
KF378614 and KF378615].Comparative analysis between VCG-1 PvRON4
(Colombian), Sal-1 (El Salvador), India VII (southern
Asia) and Mauritania I (Africa) amino acid sequences
revealed differences regarding protein length (see
Additional file 1), mainly due to large deletions bet-
ween residues 179-305 where the TRs occurred. The
first 150 amino acids corresponded to a conserved
region followed by a variable zone having repeat regions
and a highly conserved carboxy-terminal in the strains
evaluated here. Such distribution was similar to that
reported for several antigens proposed as candidates for
an anti-P. falciparum vaccine where proteins’ conserved
regions are surrounded by variable and low complexity
regions acting as immune system distractors, while im-
portant functional regions for the parasite remain poorly
recognized. The circumsporozoite protein (CSP) consists
of a central repeat region, which is diverse across Plasmo-
dium species, and flanking the repeats are two conserved
domains: region I, at the N-terminus of the repeats, and a
known C-terminal cell-adhesive adhesive motif, termed
type I thrombospondin repeat (TSR) [44]. Even though
the repeat regions’ function has not been made clear to
date, it has been found that they are species-specific, low
complexity and (in many cases) are responsible for the
diversity between different parasite isolates [45]. It has
been suggested that the presence of polymorphic repeats
affects antibody affinity maturation, thus suppressing anti-
body response to critical epitopes or adjacent regions [46].
Bioinformatics analysis of PvRON4 primary sequence
The PvRON4 amino acid sequence was scanned for
predicting different characteristics. VCG-1 PvRON4 had
Figure 3 PvRON4 expression in VCG-1 schizonts. (A) Schematic representation of PvRON4. The most relevant characteristics in the protein’s
primary sequence are shown. Red shows signal peptide location, blue a coiled-coil α-helical motif and grey the tandem repeats. Red lines
indicate conserved cysteines between Sal-1, VCG-1, Mauritania I and India VII strains. Inoculated peptides’ localization and sequence are shown in
the boxes. (B) PvRON4 recognition in schizont lysate. Lane 1: pre-immune serum; lane 2: immune serum; lane 3: immune serum pre-incubated
with inoculated peptides. (C) Immunofluorescence studies on schizonts. The arrows indicate the presence of the protein (red) and the apical
pattern suggesting its localization in the apical organelles. Blue shows schizont nuclei stained with DAPI.
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(Figure 3A) and a probable type I peptidase cleavage site
between residues S24-F25, suggesting that once the
protein has been synthesized, it is transported to be
either secreted or inserted into cell membranes. In fact,
it has been reported that PfRON4 and TgRON4 homolo-
gous proteins are secreted by the parasite towards host
cell membrane [47,48]. Bioinformatics analysis detected
no potential transmembrane domains or GPI anchors in
PvRON4, TgRON4 and PfRON4, thereby classifying
them as soluble proteins. It has been shown that some
soluble P. falciparum merozoite surface proteins, such as
MSP 3, 6, 7 and 9, are associated and/or interact with
membrane-anchored antigens [49]. Interestingly, PvRON4
contained a coiled-coil α-helical motif in its sequence
between residues 324-347 (Figure 3A) suggesting PvRON4
participation in protein-protein interaction and complex
formation. A low complexity (Figure 3A), highly variable
region was found (see Additional file 1) between residues50 to 260 containing two TRs. The first repeat consisted
of seven amino acids (GGEH/SGEH/S) and the second of
three amino acids having nine imperfect copies of G/AEH
residues. A conserved region between residues 277 and
733 was found when comparing RON4 from VCG-1 with
other P. vivax strains, such region being characterized by
having six conserved cysteines. Several functionally rele-
vant malarial antigens, such as AMA-1 and RON2, have
cysteine-containing regions forming disulphide bridges
and/or ordered 3D structures for fulfilling their biological
function [21]. However, further structural and functional
studies are needed for evaluating this conserved domain’s
importance in PvRON4 and the influence of repeat re-
gions in an immune response against PvRON4.
PvRON4 expression and localization in VCG-1 late-stage
schizonts
Anti-PvRON4 antibodies were induced in mice for
evaluating PvRON4 expression and cell localization in P.
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showed high reactivity against 35114 and 35115 peptides
(A620 0.63 ± 0.22) compared to pre-immune sera (A620
0.03 ± 0.01) (p=0.00). Sera ability to recognize PvRON4
in VCG-1 schizont lysate was then evaluated using
Western blot. Figure 3B shows that polyclonal antibodies
specifically recognized ~39 kDa and ~34 kDa bands which
were not recognized by either the pre-immune sera or
hyper-immune sera which had been pre-incubated with
the inoculated peptides. Taking a ~80 kDa predicted
PvRON4 size, two bands below the expected molecular
weight were detected, suggesting that PvRON4 under-
goes a similar proteolytic processing to that reported
for most proteins localized in the apical organelles, in-
cluding other RON proteins [47]. It has been suggested
that rhoptry proteins’ proteolytic cleavage is an essen-
tial event for maturation and/or promoting interaction
with cell surface receptors or between parasite proteins
[47,50].
The anti-PvRON4 antisera also recognized the protein
on VCG-1 late-stage schizonts, having the typical apical
organelle punctate pattern (Figure 3C) common to other
apical proteins [8,18]. Co-localization studies using anti-
bodies against PvRON4 and Pv12 showed that whileFigure 4 PvRON4 co-localization studies with Pv12 and PvRON2. Anti-
approximate localization of PvRON4 in late stage VCG-1 schizonts. As seen
membrane protein fluorescence pattern, while showing overlapping with t
The arrows indicate PvRON4 presence.Pv12 was expressed on merozoite surface with a bunch
of grapes-like pattern, PvRON4 had a punctate
pattern, not overlapping Pv12 staining (Figure 4).
When anti-PvRON4 antibodies were used with anti-
PvRON2, the staining overlapped, coinciding with
TgRON4 and PfRON4 localization in the rhoptry neck
(Figure 4). Previous studies in T. gondii and P. falcip-
arum have shown that RON4 is the only protein
where strong evidence has been produced concerning
localization in the TJ [25,51] and has been chosen as
a model for studying the dynamics of merozoite inva-
sion of RBC [25].
Conclusions
Bioinformatics and experimental analyses allowed the
identification of a new gene having three exons and
encoding the PvRON4 protein. Like PfRON4, its P. fal-
ciparum homologue, PvRON4 is expressed in late schiz-
onts and is localized in the rhoptries. Strong evidence
regarding RON4 association in the TJ and its conser-
vation in the Plasmodium genus has highlighted this
protein’s importance and the need for evaluating its
mechanism of action and association within the P. vivax
AMA1-RON complex.Pv12 and anti-PvRON2 antibodies were used for determining the
in the photo, the PvRON4 signal did not overlap with the Pv12
he pattern for the rhoptries obtained with the anti-PvRON2 antibody.
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